Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition

Abroad (travel likely)RecruitingPHASE2

Conditions

Down Syndrome · Down Syndrome, Partial Trisomy 21 · Alzheimer Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Vanderbilt University Medical Center Clinical Research Center, Nashville, Tennessee, United States
Contact: Study coordinator (Amy Boegel) · amy.r.boegel@vumc.org · 615-875-0955

Study leads

Alexander C Conley, Ph.D.
Principal Investigator
Vanderbilt University Medical Center
Paul A Newhouse, M.D.
Principal Investigator
Vanderbilt University Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1

Down Syndrome

Abroad (travel likely)RecruitingPHASE2

Aurora, United States

Down Syndrome Obstructive Sleep Apnea

Down Syndrome · Obstructive Sleep Apnea

Abroad (travel likely)RecruitingPHASE2

Los Angeles, United States · Ann Arbor, United States

Efficacy of Bumetanide to Improve Cognitive Functions in Down Syndrome

Down Syndrome

Abroad (travel likely)RecruitingPHASE2

Rome, Italy

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Coronavirus Infection (COVID-19) · Pulmonary Arterial Hypertension · Urinary Tract Infections in Children

Abroad (travel likely)Recruiting

Phoenix, United States · Little Rock, United States